Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

AHA President Michelle Albert explains what can be done to boost healthcare equity and diversity in cardiology.

AHA President Michelle Albert on addressing health equity issues in cardiology

American Heart Association President Michelle Albert, MD, talked to us about about how to address health inequities in cardiology departments.

healthcare value value-based care money dollar

CMS testing 3 new ways to lower drug prices

“HHS is using every tool available to us to lower healthcare costs and increase access to high-quality, affordable healthcare,” says HHS Secretary Xavier Becerra.

Thumbnail

Florida cardiology practice, 10 cardiologists pay $2M to settle fraud allegations

The practice and many of its cardiologists allegedly submitted false claims to Medicare, Medicaid, TRICARE and the Federal Employee Health Benefits Program. 

HHS issues guidance as COVID-19 PHE winds down

The guidance clarifies what will and will not be impacted by the sunset of the PHE on May 11.

 

Thumbnail

Americans getting more and more dissatisfied with abortion policies

A record high of 69% of U.S. adults are dissatisfied with abortion laws––the highest percentage since 2001, according to a recent Gallup poll.

Thumbnail

Atrium Health and CEO indicted in $407M healthcare fraud scheme

The scheme allegedly included cheating employees, committing mail fraud, providing inadequate care to residents and more. 

DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) clearance for LVivo IQS, a new software solution designed to help users acquire high-quality echocardiography images.

FDA clears new AI-powered cardiac imaging solution

The newly approved software uses artificial intelligence to provide users with real-time feedback related to image quality.

Thumbnail

Feds may block Amazon’s acquisition of One Medical

Amazon announced its intent to acquire One Medical in July 2022, and the $3.9 billion deal came under fire right away, with critics voicing their concerns about Amazon’s growing size and reach.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.